Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jauniaux, E.
Right arrow Articles by Campbell, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jauniaux, E.
Right arrow Articles by Campbell, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. 12, pp. 3297-3300, 1995
© 1995 European Society of Human Reproduction and Embryology


research-article

Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy

Eric Jauniaux1,2,5, Davor Jurkovic2, Beatrice Gulbis3, Corinne Liesnard4, Christoph Lees2 and Stuart Campbell2

1Academic Department of Obstetrics and Gynaecology, University College London Medical School 2Academic Department of Obstetrics and Gynaecology, King's College School of Medicine and Dentistry, University of London London, UK 3Departments of Clinical Chemistry 4Bacteriology, Academic Hospital Erasme, Free University of Brussels (ULB) Brussels, Belgium

Correspondence: 5Academic Department of Obstetrics and Gynaecology, University College London Medical School, 86–96 Chenies Mews, London WC1E 6HX, UK

Passive transfer of immunity from the mother to the first trimester fetus is of particular interest because of the reported high incidence of serious fetal sequelae due to congenital infection. We have examined the relationship between maternal serum, coelomic fluid and amniotic fluid concentrations of immunoglobulin (Ig) and complement. Ig fractions G (IgG), A (IgA), and M (IgM) and complement factors 3 (C3) and 4 (C4) were measured in 34 normal pregnancies between 6 and 12 weeks of gestation. The concentrations of specific antibodies for Toxoplasma gondii, cytomegalovirus (CMV) and rubella were also measured on 21 matched samples from the same study group. IgG and IgA concentrations were detected in all coelomic fluid samples whereas IgG was only measurable in two amniotic fluid samples. IgG and IgA concentrations were respectively 28 and 128 times lower in coelomic fluid than in maternal serum and probably reflect fetal serum concentrations. Significant positive linear correlations were found between gestational age and the coelomic concentrations of IgG (P equals; 0.001) and IgA (P = 0.014). There was no obvious association between immunoglobulin concentrations in coelomic fluid and maternal serum suggesting increasing active transport across the placenta with advancing gestation. IgM, C3 and C4 were not detected in coelomic or amniotic fluid samples. Specific antibodies were found in 13 out of 63 samples of coelomic fluid and in 32 out of 63 samples of maternal serum. They were found in coelomic fluid only if they were present in maternal serum. These results suggest that maternal IgG and IgA are potentially available to the embryo as early as the 6th week of gestation. The presence in the coelomic fluid of the IgG fraction, both total and infectious agent-specific transferred via the placenta, indicates that they may provide limited protection against congenital infection in the first trimester.

Key words: coelomic fluid/early placenta/first trimester/immunoglobulin/passive immunity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
P. L. Martin, J. B. Cornacoff, G. Treacy, E. Eirikas, J. Marini, K. L. White Jr., V. Peachee, and A. Hoberman
Effects of Administration of a Monoclonal Antibody against Mouse Tumor Necrosis Factor Alpha during Pregnancy and Lactation on the Pre- and Postnatal Development of the Mouse Immune System
International Journal of Toxicology, July 1, 2008; 27(4): 341 - 347.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Haumont, L. Delhaye, L. Garcia, M. Jurado, P. Mazzu, V. Daminet, V. Verlant, A. Bollen, R. Biemans, and A. Jacquet
Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model
Infect. Immun., September 1, 2000; 68(9): 4948 - 4953.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.